| Accession Number | 0001632901-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 31, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP & Chief Medical Officer | Common Stock | โ | Jan 29, 2026 | Exercise/Conversion | 126 | $208.90 | $26,321.40 | 126 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Common Stock | โ | Jan 29, 2026 | Sale | 126 | $520.02 | $65,522.52 | 0 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Non-Qualified Stock Option (right to buy) | Derivative | Jan 29, 2026 | Exercise/Conversion | 126 | $0.00 | $0.00 | 125 | Direct | โ | View Details | |
EVP & Chief Medical Officer | Performance Stock Units - 2-28-2023 | Derivative | Jan 28, 2026 | Grant/Award | 5,585 | $0.00 | $0.00 | 5,585 | Direct | โ | View Details |